Cubist Pharmaceuticals, Inc. (NASDAQ:CBST)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment.

Recs

0
Player Avatar pchop123 (79.80) Submitted: 11/19/2012 10:49:27 AM : Outperform Start Price: $40.27 CBST Score: +4.93

this winner's price is too low right now

Featured Broker Partners


Advertisement